| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.77B | -2.5% |
| Cost of Revenue | $3.24B | -3.0% |
| Gross Profit | $532.0M | +0.2% |
| R&D Expense | $220.0M | +15.2% |
| SG&A Expense | $202.0M | -2.4% |
| Interest Expense | $13.0M | -13.3% |
| Pre-tax Income | $338.0M | +13.4% |
| Income Tax | $125.0M | +792.9% |
| Net Income | $201.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $771.0M | +23.8% |
| Accounts Receivable | $613.0M | +6.1% |
| Inventory | $269.0M | -4.9% |
| Current Assets | $1.78B | +11.8% |
| Total Assets | $3.39B | +18.3% |
| Current Liabilities | $992.0M | +8.3% |
| Long-term Debt | $283.0M | -6.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $410.0M | -4.0% |
| Investing Cash Flow | -$181.0M | +4.2% |
| Financing Cash Flow | -$116.0M | -16.0% |
| -26.6% |
| EPS (Basic) | $7.39 | -25.6% |
| EPS (Diluted) | $7.28 | -25.9% |
| Stockholders' Equity |
| $1.57B |
| +27.6% |